Global Enzyme Replacement Therapy Databank Market Report

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,000	100 Pages	Magna Intelligence	April, 2024	MAIN18750036

Best Price Guarantee
Price	from $2,000
Length	100 Pages
Publisher	Magna Intelligence
Published Date	April, 2024
SKU	MAIN18750036

Global Enzyme Replacement Therapy Databank Market Report

The Enzyme Replacement Therapy market was valued at $8,215.6 Million in 2022, and is projected to reach $14,255.8 Million by 2031 growing at a CAGR of 6.36% from 2023 to 2031. Imiglucerase segment is expected to be the highest contributor to this market, with $1,759.5 Million in 2022, and is anticipated to reach $2,701.4 Million by 2031, registering a CAGR of 4.92%. Galsulfase segment is anticipated to reach $984.4 Million by 2031 with the highest CAGR of 8.95%. Imiglucerase and Agalsidase Beta segments collectively expected to account for about 40.2% share of the Enzyme Replacement Therapy market in 2022, with the former constituting around 21.4% share. Galsulfase and Velaglucerase Alfa segments are expected to witness significant growth rates at a CAGR of 8.95% and 8.56% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 16.1% in the overall Enzyme Replacement Therapy market in 2022, and is anticipated to reach 19.6% by 2031.

1. Global Enzyme Replacement Therapy Market, By Enzyme: 1.1. Overview; 1.2. Imiglucerase; 1.2.1 Imiglucerase Market, By Region; 1.2.1.1 North America Imiglucerase Market, By Country; 1.2.1.2 Europe Imiglucerase Market, By Country; 1.2.1.3 Asia-Pacific Imiglucerase Market, By Country; 1.2.1.4 Rest of World Imiglucerase Market, By Country; 1.3. Agalsidase Beta; 1.3.1 Agalsidase Beta Market, By Region; 1.3.1.1 North America Agalsidase Beta Market, By Country; 1.3.1.2 Europe Agalsidase Beta Market, By Country; 1.3.1.3 Asia-Pacific Agalsidase Beta Market, By Country; 1.3.1.4 Rest of World Agalsidase Beta Market, By Country; 1.4. Taliglucerase; 1.4.1 Taliglucerase Market, By Region; 1.4.1.1 North America Taliglucerase Market, By Country; 1.4.1.2 Europe Taliglucerase Market, By Country; 1.4.1.3 Asia-Pacific Taliglucerase Market, By Country; 1.4.1.4 Rest of World Taliglucerase Market, By Country; 1.5. Velaglucerase Alfa; 1.5.1 Velaglucerase Alfa Market, By Region; 1.5.1.1 North America Velaglucerase Alfa Market, By Country; 1.5.1.2 Europe Velaglucerase Alfa Market, By Country; 1.5.1.3 Asia-Pacific Velaglucerase Alfa Market, By Country; 1.5.1.4 Rest of World Velaglucerase Alfa Market, By Country; 1.6. Laronidase; 1.6.1 Laronidase Market, By Region; 1.6.1.1 North America Laronidase Market, By Country; 1.6.1.2 Europe Laronidase Market, By Country; 1.6.1.3 Asia-Pacific Laronidase Market, By Country; 1.6.1.4 Rest of World Laronidase Market, By Country; 1.7. Alglucosidase Alfa; 1.7.1 Alglucosidase Alfa Market, By Region; 1.7.1.1 North America Alglucosidase Alfa Market, By Country; 1.7.1.2 Europe Alglucosidase Alfa Market, By Country; 1.7.1.3 Asia-Pacific Alglucosidase Alfa Market, By Country; 1.7.1.4 Rest of World Alglucosidase Alfa Market, By Country; 1.8. Galsulfase; 1.8.1 Galsulfase Market, By Region; 1.8.1.1 North America Galsulfase Market, By Country; 1.8.1.2 Europe Galsulfase Market, By Country; 1.8.1.3 Asia-Pacific Galsulfase Market, By Country; 1.8.1.4 Rest of World Galsulfase Market, By Country; 1.9. Idursulfase; 1.9.1 Idursulfase Market, By Region; 1.9.1.1 North America Idursulfase Market, By Country; 1.9.1.2 Europe Idursulfase Market, By Country; 1.9.1.3 Asia-Pacific Idursulfase Market, By Country; 1.9.1.4 Rest of World Idursulfase Market, By Country; 1.10. Pancreatic Enzymes; 1.10.1 Pancreatic Enzymes Market, By Region; 1.10.1.1 North America Pancreatic Enzymes Market, By Country; 1.10.1.2 Europe Pancreatic Enzymes Market, By Country; 1.10.1.3 Asia-Pacific Pancreatic Enzymes Market, By Country; 1.10.1.4 Rest of World Pancreatic Enzymes Market, By Country; 1.11. Pegademase; 1.11.1 Pegademase Market, By Region; 1.11.1.1 North America Pegademase Market, By Country; 1.11.1.2 Europe Pegademase Market, By Country; 1.11.1.3 Asia-Pacific Pegademase Market, By Country; 1.11.1.4 Rest of World Pegademase Market, By Country; 1.12. Other Enzymes; 1.12.1 Other Enzymes Market, By Region; 1.12.1.1 North America Other Enzymes Market, By Country; 1.12.1.2 Europe Other Enzymes Market, By Country; 1.12.1.3 Asia-Pacific Other Enzymes Market, By Country; 1.12.1.4 Rest of World Other Enzymes Market, By Country
2. Global Enzyme Replacement Therapy Market, By Therapeutic Condition: 2.1. Overview; 2.2. Gaucher Disease; 2.2.1 Gaucher Disease Market, By Region; 2.2.1.1 North America Gaucher Disease Market, By Country; 2.2.1.2 Europe Gaucher Disease Market, By Country; 2.2.1.3 Asia-Pacific Gaucher Disease Market, By Country; 2.2.1.4 Rest of World Gaucher Disease Market, By Country; 2.3. Fabry Disease; 2.3.1 Fabry Disease Market, By Region; 2.3.1.1 North America Fabry Disease Market, By Country; 2.3.1.2 Europe Fabry Disease Market, By Country; 2.3.1.3 Asia-Pacific Fabry Disease Market, By Country; 2.3.1.4 Rest of World Fabry Disease Market, By Country; 2.4. Pompe Disease; 2.4.1 Pompe Disease Market, By Region; 2.4.1.1 North America Pompe Disease Market, By Country; 2.4.1.2 Europe Pompe Disease Market, By Country; 2.4.1.3 Asia-Pacific Pompe Disease Market, By Country; 2.4.1.4 Rest of World Pompe Disease Market, By Country; 2.5. SCID; 2.5.1 SCID Market, By Region; 2.5.1.1 North America SCID Market, By Country; 2.5.1.2 Europe SCID Market, By Country; 2.5.1.3 Asia-Pacific SCID Market, By Country; 2.5.1.4 Rest of World SCID Market, By Country; 2.6. MPS; 2.6.1 MPS Market, By Region; 2.6.1.1 North America MPS Market, By Country; 2.6.1.2 Europe MPS Market, By Country; 2.6.1.3 Asia-Pacific MPS Market, By Country; 2.6.1.4 Rest of World MPS Market, By Country; 2.7. Other Therapeutic Conditions; 2.7.1 Other Therapeutic Conditions Market, By Region; 2.7.1.1 North America Other Therapeutic Conditions Market, By Country; 2.7.1.2 Europe Other Therapeutic Conditions Market, By Country; 2.7.1.3 Asia-Pacific Other Therapeutic Conditions Market, By Country; 2.7.1.4 Rest of World Other Therapeutic Conditions Market, By Country
3. Global Enzyme Replacement Therapy Market, By Route of Administration: 3.1. Overview; 3.2. Oral; 3.2.1 Oral Market, By Region; 3.2.1.1 North America Oral Market, By Country; 3.2.1.2 Europe Oral Market, By Country; 3.2.1.3 Asia-Pacific Oral Market, By Country; 3.2.1.4 Rest of World Oral Market, By Country; 3.3. Parenteral; 3.3.1 Parenteral Market, By Region; 3.3.1.1 North America Parenteral Market, By Country; 3.3.1.2 Europe Parenteral Market, By Country; 3.3.1.3 Asia-Pacific Parenteral Market, By Country; 3.3.1.4 Rest of World Parenteral Market, By Country
4. Global Enzyme Replacement Therapy Market, By End-Use: 4.1. Overview; 4.2. Hospitals; 4.2.1 Hospitals Market, By Region; 4.2.1.1 North America Hospitals Market, By Country; 4.2.1.2 Europe Hospitals Market, By Country; 4.2.1.3 Asia-Pacific Hospitals Market, By Country; 4.2.1.4 Rest of World Hospitals Market, By Country; 4.3. Infusion Centers; 4.3.1 Infusion Centers Market, By Region; 4.3.1.1 North America Infusion Centers Market, By Country; 4.3.1.2 Europe Infusion Centers Market, By Country; 4.3.1.3 Asia-Pacific Infusion Centers Market, By Country; 4.3.1.4 Rest of World Infusion Centers Market, By Country; 4.4. Other End-Uses; 4.4.1 Other End-Uses Market, By Region; 4.4.1.1 North America Other End-Uses Market, By Country; 4.4.1.2 Europe Other End-Uses Market, By Country; 4.4.1.3 Asia-Pacific Other End-Uses Market, By Country; 4.4.1.4 Rest of World Other End-Uses Market, By Country
5. Global Enzyme Replacement Therapy Market, By Region: 5.1. Overview; 5.2. North America; 5.2.1 North America Enzyme Replacement Therapy Market, By Enzyme; 5.2.2 North America Enzyme Replacement Therapy Market, By Therapeutic Condition; 5.2.3 North America Enzyme Replacement Therapy Market, By Route of Administration; 5.2.4 North America Enzyme Replacement Therapy Market, By End-Use; 5.2.5 North America Enzyme Replacement Therapy Market, By Country; 5.2.5.1 U.S.; 5.2.5.1.1 U.S. Enzyme Replacement Therapy Market, By Enzyme; 5.2.5.1.2 U.S. Enzyme Replacement Therapy Market, By Therapeutic Condition; 5.2.5.1.3 U.S. Enzyme Replacement Therapy Market, By Route of Administration; 5.2.5.1.4 U.S. Enzyme Replacement Therapy Market, By End-Use; 5.2.5.2 Canada; 5.2.5.2.1 Canada Enzyme Replacement Therapy Market, By Enzyme; 5.2.5.2.2 Canada Enzyme Replacement Therapy Market, By Therapeutic Condition; 5.2.5.2.3 Canada Enzyme Replacement Therapy Market, By Route of Administration; 5.2.5.2.4 Canada Enzyme Replacement Therapy Market, By End-Use; 5.3. Europe; 5.3.1 Europe Enzyme Replacement Therapy Market, By Enzyme; 5.3.2 Europe Enzyme Replacement Therapy Market, By Therapeutic Condition; 5.3.3 Europe Enzyme Replacement Therapy Market, By Route of Administration; 5.3.4 Europe Enzyme Replacement Therapy Market, By End-Use; 5.3.5 Europe Enzyme Replacement Therapy Market, By Country; 5.3.5.1 Germany; 5.3.5.1.1 Germany Enzyme Replacement Therapy Market, By Enzyme; 5.3.5.1.2 Germany Enzyme Replacement Therapy Market, By Therapeutic Condition; 5.3.5.1.3 Germany Enzyme Replacement Therapy Market, By Route of Administration; 5.3.5.1.4 Germany Enzyme Replacement Therapy Market, By End-Use; 5.3.5.2 U.K.; 5.3.5.2.1 U.K. Enzyme Replacement Therapy Market, By Enzyme; 5.3.5.2.2 U.K. Enzyme Replacement Therapy Market, By Therapeutic Condition; 5.3.5.2.3 U.K. Enzyme Replacement Therapy Market, By Route of Administration; 5.3.5.2.4 U.K. Enzyme Replacement Therapy Market, By End-Use; 5.3.5.3 France; 5.3.5.3.1 France Enzyme Replacement Therapy Market, By Enzyme; 5.3.5.3.2 France Enzyme Replacement Therapy Market, By Therapeutic Condition; 5.3.5.3.3 France Enzyme Replacement Therapy Market, By Route of Administration; 5.3.5.3.4 France Enzyme Replacement Therapy Market, By End-Use; 5.3.5.4 Italy; 5.3.5.4.1 Italy Enzyme Replacement Therapy Market, By Enzyme; 5.3.5.4.2 Italy Enzyme Replacement Therapy Market, By Therapeutic Condition; 5.3.5.4.3 Italy Enzyme Replacement Therapy Market, By Route of Administration; 5.3.5.4.4 Italy Enzyme Replacement Therapy Market, By End-Use; 5.3.5.5 Spain; 5.3.5.5.1 Spain Enzyme Replacement Therapy Market, By Enzyme; 5.3.5.5.2 Spain Enzyme Replacement Therapy Market, By Therapeutic Condition; 5.3.5.5.3 Spain Enzyme Replacement Therapy Market, By Route of Administration; 5.3.5.5.4 Spain Enzyme Replacement Therapy Market, By End-Use; 5.3.5.6 Rest of Europe; 5.3.5.6.1 Rest of Europe Enzyme Replacement Therapy Market, By Enzyme; 5.3.5.6.2 Rest of Europe Enzyme Replacement Therapy Market, By Therapeutic Condition; 5.3.5.6.3 Rest of Europe Enzyme Replacement Therapy Market, By Route of Administration; 5.3.5.6.4 Rest of Europe Enzyme Replacement Therapy Market, By End-Use; 5.4. Asia-Pacific; 5.4.1 Asia-Pacific Enzyme Replacement Therapy Market, By Enzyme; 5.4.2 Asia-Pacific Enzyme Replacement Therapy Market, By Therapeutic Condition; 5.4.3 Asia-Pacific Enzyme Replacement Therapy Market, By Route of Administration; 5.4.4 Asia-Pacific Enzyme Replacement Therapy Market, By End-Use; 5.4.5 Asia-Pacific Enzyme Replacement Therapy Market, By Country; 5.4.5.1 China; 5.4.5.1.1 China Enzyme Replacement Therapy Market, By Enzyme; 5.4.5.1.2 China Enzyme Replacement Therapy Market, By Therapeutic Condition; 5.4.5.1.3 China Enzyme Replacement Therapy Market, By Route of Administration; 5.4.5.1.4 China Enzyme Replacement Therapy Market, By End-Use; 5.4.5.2 Japan; 5.4.5.2.1 Japan Enzyme Replacement Therapy Market, By Enzyme; 5.4.5.2.2 Japan Enzyme Replacement Therapy Market, By Therapeutic Condition; 5.4.5.2.3 Japan Enzyme Replacement Therapy Market, By Route of Administration; 5.4.5.2.4 Japan Enzyme Replacement Therapy Market, By End-Use; 5.4.5.3 South Korea; 5.4.5.3.1 South Korea Enzyme Replacement Therapy Market, By Enzyme; 5.4.5.3.2 South Korea Enzyme Replacement Therapy Market, By Therapeutic Condition; 5.4.5.3.3 South Korea Enzyme Replacement Therapy Market, By Route of Administration; 5.4.5.3.4 South Korea Enzyme Replacement Therapy Market, By End-Use; 5.4.5.4 India; 5.4.5.4.1 India Enzyme Replacement Therapy Market, By Enzyme; 5.4.5.4.2 India Enzyme Replacement Therapy Market, By Therapeutic Condition; 5.4.5.4.3 India Enzyme Replacement Therapy Market, By Route of Administration; 5.4.5.4.4 India Enzyme Replacement Therapy Market, By End-Use; 5.4.5.5 Singapore; 5.4.5.5.1 Singapore Enzyme Replacement Therapy Market, By Enzyme; 5.4.5.5.2 Singapore Enzyme Replacement Therapy Market, By Therapeutic Condition; 5.4.5.5.3 Singapore Enzyme Replacement Therapy Market, By Route of Administration; 5.4.5.5.4 Singapore Enzyme Replacement Therapy Market, By End-Use; 5.4.5.6 Rest of Asia; 5.4.5.6.1 Rest of Asia Enzyme Replacement Therapy Market, By Enzyme; 5.4.5.6.2 Rest of Asia Enzyme Replacement Therapy Market, By Therapeutic Condition; 5.4.5.6.3 Rest of Asia Enzyme Replacement Therapy Market, By Route of Administration; 5.4.5.6.4 Rest of Asia Enzyme Replacement Therapy Market, By End-Use; 5.5. Rest of World; 5.5.1 Rest of World Enzyme Replacement Therapy Market, By Enzyme; 5.5.2 Rest of World Enzyme Replacement Therapy Market, By Therapeutic Condition; 5.5.3 Rest of World Enzyme Replacement Therapy Market, By Route of Administration; 5.5.4 Rest of World Enzyme Replacement Therapy Market, By End-Use; 5.5.5 Rest of World Enzyme Replacement Therapy Market, By Country; 5.5.5.1 Brazil; 5.5.5.1.1 Brazil Enzyme Replacement Therapy Market, By Enzyme; 5.5.5.1.2 Brazil Enzyme Replacement Therapy Market, By Therapeutic Condition; 5.5.5.1.3 Brazil Enzyme Replacement Therapy Market, By Route of Administration; 5.5.5.1.4 Brazil Enzyme Replacement Therapy Market, By End-Use; 5.5.5.2 Mexico; 5.5.5.2.1 Mexico Enzyme Replacement Therapy Market, By Enzyme; 5.5.5.2.2 Mexico Enzyme Replacement Therapy Market, By Therapeutic Condition; 5.5.5.2.3 Mexico Enzyme Replacement Therapy Market, By Route of Administration; 5.5.5.2.4 Mexico Enzyme Replacement Therapy Market, By End-Use; 5.5.5.3 South Africa; 5.5.5.3.1 South Africa Enzyme Replacement Therapy Market, By Enzyme; 5.5.5.3.2 South Africa Enzyme Replacement Therapy Market, By Therapeutic Condition; 5.5.5.3.3 South Africa Enzyme Replacement Therapy Market, By Route of Administration; 5.5.5.3.4 South Africa Enzyme Replacement Therapy Market, By End-Use; 5.5.5.4 Australia; 5.5.5.4.1 Australia Enzyme Replacement Therapy Market, By Enzyme; 5.5.5.4.2 Australia Enzyme Replacement Therapy Market, By Therapeutic Condition; 5.5.5.4.3 Australia Enzyme Replacement Therapy Market, By Route of Administration; 5.5.5.4.4 Australia Enzyme Replacement Therapy Market, By End-Use; 5.5.5.5 ROW Countries; 5.5.5.5.1 ROW Countries Enzyme Replacement Therapy Market, By Enzyme; 5.5.5.5.2 ROW Countries Enzyme Replacement Therapy Market, By Therapeutic Condition; 5.5.5.5.3 ROW Countries Enzyme Replacement Therapy Market, By Route of Administration; 5.5.5.5.4 ROW Countries Enzyme Replacement Therapy Market, By End-Use; ROW Countries Enzyme Replacement Therapy Market Value, By End-Use, 2022-2031, Million USD LIST OF TABLES; TABLE 1. Global Enzyme Replacement Therapy Market Value, By Enzyme, 2022-2031, Million USD; TABLE 2. Imiglucerase Market Value, By Region, 2022-2031, Million USD; TABLE 3. North America Imiglucerase Market Value, By Country, 2022-2031, Million USD; TABLE 4. Europe Imiglucerase Market Value, By Country, 2022-2031, Million USD; TABLE 5. Asia-Pacific Imiglucerase Market Value, By Country, 2022-2031, Million USD; TABLE 6. Rest of World Imiglucerase Market Value, By Country, 2022-2031, Million USD; TABLE 7. Agalsidase Beta Market Value, By Region, 2022-2031, Million USD; TABLE 8. North America Agalsidase Beta Market Value, By Country, 2022-2031, Million USD; TABLE 9. Europe Agalsidase Beta Market Value, By Country, 2022-2031, Million USD; TABLE 10. Asia-Pacific Agalsidase Beta Market Value, By Country, 2022-2031, Million USD; TABLE 11. Rest of World Agalsidase Beta Market Value, By Country, 2022-2031, Million USD; TABLE 12. Taliglucerase Market Value, By Region, 2022-2031, Million USD; TABLE 13. North America Taliglucerase Market Value, By Country, 2022-2031, Million USD; TABLE 14. Europe Taliglucerase Market Value, By Country, 2022-2031, Million USD; TABLE 15. Asia-Pacific Taliglucerase Market Value, By Country, 2022-2031, Million USD; TABLE 16. Rest of World Taliglucerase Market Value, By Country, 2022-2031, Million USD; TABLE 17. Velaglucerase Alfa Market Value, By Region, 2022-2031, Million USD; TABLE 18. North America Velaglucerase Alfa Market Value, By Country, 2022-2031, Million USD; TABLE 19. Europe Velaglucerase Alfa Market Value, By Country, 2022-2031, Million USD; TABLE 20. Asia-Pacific Velaglucerase Alfa Market Value, By Country, 2022-2031, Million USD; TABLE 21. Rest of World Velaglucerase Alfa Market Value, By Country, 2022-2031, Million USD; TABLE 22. Laronidase Market Value, By Region, 2022-2031, Million USD; TABLE 23. North America Laronidase Market Value, By Country, 2022-2031, Million USD; TABLE 24. Europe Laronidase Market Value, By Country, 2022-2031, Million USD; TABLE 25. Asia-Pacific Laronidase Market Value, By Country, 2022-2031, Million USD; TABLE 26. Rest of World Laronidase Market Value, By Country, 2022-2031, Million USD; TABLE 27. Alglucosidase Alfa Market Value, By Region, 2022-2031, Million USD; TABLE 28. North America Alglucosidase Alfa Market Value, By Country, 2022-2031, Million USD; TABLE 29. Europe Alglucosidase Alfa Market Value, By Country, 2022-2031, Million USD; TABLE 30. Asia-Pacific Alglucosidase Alfa Market Value, By Country, 2022-2031, Million USD; TABLE 31. Rest of World Alglucosidase Alfa Market Value, By Country, 2022-2031, Million USD; TABLE 32. Galsulfase Market Value, By Region, 2022-2031, Million USD; TABLE 33. North America Galsulfase Market Value, By Country, 2022-2031, Million USD; TABLE 34. Europe Galsulfase Market Value, By Country, 2022-2031, Million USD; TABLE 35. Asia-Pacific Galsulfase Market Value, By Country, 2022-2031, Million USD; TABLE 36. Rest of World Galsulfase Market Value, By Country, 2022-2031, Million USD; TABLE 37. Idursulfase Market Value, By Region, 2022-2031, Million USD; TABLE 38. North America Idursulfase Market Value, By Country, 2022-2031, Million USD; TABLE 39. Europe Idursulfase Market Value, By Country, 2022-2031, Million USD; TABLE 40. Asia-Pacific Idursulfase Market Value, By Country, 2022-2031, Million USD; TABLE 41. Rest of World Idursulfase Market Value, By Country, 2022-2031, Million USD; TABLE 42. Pancreatic Enzymes Market Value, By Region, 2022-2031, Million USD; TABLE 43. North America Pancreatic Enzymes Market Value, By Country, 2022-2031, Million USD; TABLE 44. Europe Pancreatic Enzymes Market Value, By Country, 2022-2031, Million USD; TABLE 45. Asia-Pacific Pancreatic Enzymes Market Value, By Country, 2022-2031, Million USD; TABLE 46. Rest of World Pancreatic Enzymes Market Value, By Country, 2022-2031, Million USD; TABLE 47. Pegademase Market Value, By Region, 2022-2031, Million USD; TABLE 48. North America Pegademase Market Value, By Country, 2022-2031, Million USD; TABLE 49. Europe Pegademase Market Value, By Country, 2022-2031, Million USD; TABLE 50. Asia-Pacific Pegademase Market Value, By Country, 2022-2031, Million USD; TABLE 51. Rest of World Pegademase Market Value, By Country, 2022-2031, Million USD; TABLE 52. Other Enzymes Market Value, By Region, 2022-2031, Million USD; TABLE 53. North America Other Enzymes Market Value, By Country, 2022-2031, Million USD; TABLE 54. Europe Other Enzymes Market Value, By Country, 2022-2031, Million USD; TABLE 55. Asia-Pacific Other Enzymes Market Value, By Country, 2022-2031, Million USD; TABLE 56. Rest of World Other Enzymes Market Value, By Country, 2022-2031, Million USD; TABLE 57. Global Enzyme Replacement Therapy Market Value, By Therapeutic Condition, 2022-2031, Million USD; TABLE 58. Gaucher Disease Market Value, By Region, 2022-2031, Million USD; TABLE 59. North America Gaucher Disease Market Value, By Country, 2022-2031, Million USD; TABLE 60. Europe Gaucher Disease Market Value, By Country, 2022-2031, Million USD; TABLE 61. Asia-Pacific Gaucher Disease Market Value, By Country, 2022-2031, Million USD; TABLE 62. Rest of World Gaucher Disease Market Value, By Country, 2022-2031, Million USD; TABLE 63. Fabry Disease Market Value, By Region, 2022-2031, Million USD; TABLE 64. North America Fabry Disease Market Value, By Country, 2022-2031, Million USD; TABLE 65. Europe Fabry Disease Market Value, By Country, 2022-2031, Million USD; TABLE 66. Asia-Pacific Fabry Disease Market Value, By Country, 2022-2031, Million USD; TABLE 67. Rest of World Fabry Disease Market Value, By Country, 2022-2031, Million USD; TABLE 68. Pompe Disease Market Value, By Region, 2022-2031, Million USD; TABLE 69. North America Pompe Disease Market Value, By Country, 2022-2031, Million USD; TABLE 70. Europe Pompe Disease Market Value, By Country, 2022-2031, Million USD; TABLE 71. Asia-Pacific Pompe Disease Market Value, By Country, 2022-2031, Million USD; TABLE 72. Rest of World Pompe Disease Market Value, By Country, 2022-2031, Million USD; TABLE 73. SCID Market Value, By Region, 2022-2031, Million USD; TABLE 74. North America SCID Market Value, By Country, 2022-2031, Million USD; TABLE 75. Europe SCID Market Value, By Country, 2022-2031, Million USD; TABLE 76. Asia-Pacific SCID Market Value, By Country, 2022-2031, Million USD; TABLE 77. Rest of World SCID Market Value, By Country, 2022-2031, Million USD; TABLE 78. MPS Market Value, By Region, 2022-2031, Million USD; TABLE 79. North America MPS Market Value, By Country, 2022-2031, Million USD; TABLE 80. Europe MPS Market Value, By Country, 2022-2031, Million USD; TABLE 81. Asia-Pacific MPS Market Value, By Country, 2022-2031, Million USD; TABLE 82. Rest of World MPS Market Value, By Country, 2022-2031, Million USD; TABLE 83. Other Therapeutic Conditions Market Value, By Region, 2022-2031, Million USD; TABLE 84. North America Other Therapeutic Conditions Market Value, By Country, 2022-2031, Million USD; TABLE 85. Europe Other Therapeutic Conditions Market Value, By Country, 2022-2031, Million USD; TABLE 86. Asia-Pacific Other Therapeutic Conditions Market Value, By Country, 2022-2031, Million USD; TABLE 87. Rest of World Other Therapeutic Conditions Market Value, By Country, 2022-2031, Million USD; TABLE 88. Global Enzyme Replacement Therapy Market Value, By Route of Administration, 2022-2031, Million USD; TABLE 89. Oral Market Value, By Region, 2022-2031, Million USD; TABLE 90. North America Oral Market Value, By Country, 2022-2031, Million USD; TABLE 91. Europe Oral Market Value, By Country, 2022-2031, Million USD; TABLE 92. Asia-Pacific Oral Market Value, By Country, 2022-2031, Million USD; TABLE 93. Rest of World Oral Market Value, By Country, 2022-2031, Million USD; TABLE 94. Parenteral Market Value, By Region, 2022-2031, Million USD; TABLE 95. North America Parenteral Market Value, By Country, 2022-2031, Million USD; TABLE 96. Europe Parenteral Market Value, By Country, 2022-2031, Million USD; TABLE 97. Asia-Pacific Parenteral Market Value, By Country, 2022-2031, Million USD; TABLE 98. Rest of World Parenteral Market Value, By Country, 2022-2031, Million USD; TABLE 99. Global Enzyme Replacement Therapy Market Value, By End-Use, 2022-2031, Million USD; TABLE 100. Hospitals Market Value, By Region, 2022-2031, Million USD; TABLE 101. North America Hospitals Market Value, By Country, 2022-2031, Million USD; TABLE 102. Europe Hospitals Market Value, By Country, 2022-2031, Million USD; TABLE 103. Asia-Pacific Hospitals Market Value, By Country, 2022-2031, Million USD; TABLE 104. Rest of World Hospitals Market Value, By Country, 2022-2031, Million USD; TABLE 105. Infusion Centers Market Value, By Region, 2022-2031, Million USD; TABLE 106. North America Infusion Centers Market Value, By Country, 2022-2031, Million USD; TABLE 107. Europe Infusion Centers Market Value, By Country, 2022-2031, Million USD; TABLE 108. Asia-Pacific Infusion Centers Market Value, By Country, 2022-2031, Million USD; TABLE 109. Rest of World Infusion Centers Market Value, By Country, 2022-2031, Million USD; TABLE 110. Other End-Uses Market Value, By Region, 2022-2031, Million USD; TABLE 111. North America Other End-Uses Market Value, By Country, 2022-2031, Million USD; TABLE 112. Europe Other End-Uses Market Value, By Country, 2022-2031, Million USD; TABLE 113. Asia-Pacific Other End-Uses Market Value, By Country, 2022-2031, Million USD; TABLE 114. Rest of World Other End-Uses Market Value, By Country, 2022-2031, Million USD; TABLE 115. Global Enzyme Replacement Therapy Market Value, By Region, 2022-2031, Million USD; TABLE 116. North America Enzyme Replacement Therapy Market Value, By Enzyme, 2022-2031, Million USD; TABLE 117. North America Enzyme Replacement Therapy Market Value, By Therapeutic Condition, 2022-2031, Million USD; TABLE 118. North America Enzyme Replacement Therapy Market Value, By Route of Administration, 2022-2031, Million USD; TABLE 119. North America Enzyme Replacement Therapy Market Value, By End-Use, 2022-2031, Million USD; TABLE 120. North America Enzyme Replacement Therapy Market Value, By Country, 2022-2031, Million USD; TABLE 121. U.S. Enzyme Replacement Therapy Market Value, By Enzyme, 2022-2031, Million USD; TABLE 122. U.S. Enzyme Replacement Therapy Market Value, By Therapeutic Condition, 2022-2031, Million USD; TABLE 123. U.S. Enzyme Replacement Therapy Market Value, By Route of Administration, 2022-2031, Million USD; TABLE 124. U.S. Enzyme Replacement Therapy Market Value, By End-Use, 2022-2031, Million USD; TABLE 125. Canada Enzyme Replacement Therapy Market Value, By Enzyme, 2022-2031, Million USD; TABLE 126. Canada Enzyme Replacement Therapy Market Value, By Therapeutic Condition, 2022-2031, Million USD; TABLE 127. Canada Enzyme Replacement Therapy Market Value, By Route of Administration, 2022-2031, Million USD; TABLE 128. Canada Enzyme Replacement Therapy Market Value, By End-Use, 2022-2031, Million USD; TABLE 129. Europe Enzyme Replacement Therapy Market Value, By Enzyme, 2022-2031, Million USD; TABLE 130. Europe Enzyme Replacement Therapy Market Value, By Therapeutic Condition, 2022-2031, Million USD; TABLE 131. Europe Enzyme Replacement Therapy Market Value, By Route of Administration, 2022-2031, Million USD; TABLE 132. Europe Enzyme Replacement Therapy Market Value, By End-Use, 2022-2031, Million USD; TABLE 133. Europe Enzyme Replacement Therapy Market Value, By Country, 2022-2031, Million USD; TABLE 134. Germany Enzyme Replacement Therapy Market Value, By Enzyme, 2022-2031, Million USD; TABLE 135. Germany Enzyme Replacement Therapy Market Value, By Therapeutic Condition, 2022-2031, Million USD; TABLE 136. Germany Enzyme Replacement Therapy Market Value, By Route of Administration, 2022-2031, Million USD; TABLE 137. Germany Enzyme Replacement Therapy Market Value, By End-Use, 2022-2031, Million USD; TABLE 138. U.K. Enzyme Replacement Therapy Market Value, By Enzyme, 2022-2031, Million USD; TABLE 139. U.K. Enzyme Replacement Therapy Market Value, By Therapeutic Condition, 2022-2031, Million USD; TABLE 140. U.K. Enzyme Replacement Therapy Market Value, By Route of Administration, 2022-2031, Million USD; TABLE 141. U.K. Enzyme Replacement Therapy Market Value, By End-Use, 2022-2031, Million USD; TABLE 142. France Enzyme Replacement Therapy Market Value, By Enzyme, 2022-2031, Million USD; TABLE 143. France Enzyme Replacement Therapy Market Value, By Therapeutic Condition, 2022-2031, Million USD; TABLE 144. France Enzyme Replacement Therapy Market Value, By Route of Administration, 2022-2031, Million USD; TABLE 145. France Enzyme Replacement Therapy Market Value, By End-Use, 2022-2031, Million USD; TABLE 146. Italy Enzyme Replacement Therapy Market Value, By Enzyme, 2022-2031, Million USD; TABLE 147. Italy Enzyme Replacement Therapy Market Value, By Therapeutic Condition, 2022-2031, Million USD; TABLE 148. Italy Enzyme Replacement Therapy Market Value, By Route of Administration, 2022-2031, Million USD; TABLE 149. Italy Enzyme Replacement Therapy Market Value, By End-Use, 2022-2031, Million USD; TABLE 150. Spain Enzyme Replacement Therapy Market Value, By Enzyme, 2022-2031, Million USD; TABLE 151. Spain Enzyme Replacement Therapy Market Value, By Therapeutic Condition, 2022-2031, Million USD; TABLE 152. Spain Enzyme Replacement Therapy Market Value, By Route of Administration, 2022-2031, Million USD; TABLE 153. Spain Enzyme Replacement Therapy Market Value, By End-Use, 2022-2031, Million USD; TABLE 154. Rest of Europe Enzyme Replacement Therapy Market Value, By Enzyme, 2022-2031, Million USD; TABLE 155. Rest of Europe Enzyme Replacement Therapy Market Value, By Therapeutic Condition, 2022-2031, Million USD; TABLE 156. Rest of Europe Enzyme Replacement Therapy Market Value, By Route of Administration, 2022-2031, Million USD; TABLE 157. Rest of Europe Enzyme Replacement Therapy Market Value, By End-Use, 2022-2031, Million USD; TABLE 158. Asia-Pacific Enzyme Replacement Therapy Market Value, By Enzyme, 2022-2031, Million USD; TABLE 159. Asia-Pacific Enzyme Replacement Therapy Market Value, By Therapeutic Condition, 2022-2031, Million USD; TABLE 160. Asia-Pacific Enzyme Replacement Therapy Market Value, By Route of Administration, 2022-2031, Million USD; TABLE 161. Asia-Pacific Enzyme Replacement Therapy Market Value, By End-Use, 2022-2031, Million USD; TABLE 162. Asia-Pacific Enzyme Replacement Therapy Market Value, By Country, 2022-2031, Million USD; TABLE 163. China Enzyme Replacement Therapy Market Value, By Enzyme, 2022-2031, Million USD; TABLE 164. China Enzyme Replacement Therapy Market Value, By Therapeutic Condition, 2022-2031, Million USD; TABLE 165. China Enzyme Replacement Therapy Market Value, By Route of Administration, 2022-2031, Million USD; TABLE 166. China Enzyme Replacement Therapy Market Value, By End-Use, 2022-2031, Million USD; TABLE 167. Japan Enzyme Replacement Therapy Market Value, By Enzyme, 2022-2031, Million USD; TABLE 168. Japan Enzyme Replacement Therapy Market Value, By Therapeutic Condition, 2022-2031, Million USD; TABLE 169. Japan Enzyme Replacement Therapy Market Value, By Route of Administration, 2022-2031, Million USD; TABLE 170. Japan Enzyme Replacement Therapy Market Value, By End-Use, 2022-2031, Million USD; TABLE 171. South Korea Enzyme Replacement Therapy Market Value, By Enzyme, 2022-2031, Million USD; TABLE 172. South Korea Enzyme Replacement Therapy Market Value, By Therapeutic Condition, 2022-2031, Million USD; TABLE 173. South Korea Enzyme Replacement Therapy Market Value, By Route of Administration, 2022-2031, Million USD; TABLE 174. South Korea Enzyme Replacement Therapy Market Value, By End-Use, 2022-2031, Million USD